Keywords: prostatic neoplasms; biomarkers; early detection of cancer; prognosis; DRE; digital rectal examination; FDA; Food and Drug Administration; mpMRI; multiparametric MRI; MRI; magnetic resonance imaging; NCCN®; National Comprehensive Cancer Network®; PCA3;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: prostatic neoplasms; biological markers; sensitivity and specificity; prostate-specific antigen; risk; AS; active surveillance; BCR; biochemical recurrence; CAPRA-S; Cancer of the Prostate Risk Assessment Postsurgical; CCP; cell cycle progression; DRE; di
Keywords: Prostate cancer; Biomarkers; Urine; PCA3; TMPRSS2:ERG; GSTP1; Metabolomics; Microbiota;
Keywords: PHI; PCA3; Radical prostatectomy; Prostate cancer; Prognostic accuracy; Active surveillance;
Keywords: Prostate cancer; PCA3; Carcinogenesis; Genomic classification
Keywords: Biomarkers; Prostate; Screening; TRUS; PSA; PCA3; TMPRSS2:ERG; Prostate Health Index;
Keywords: Repeat prostate biopsy; Transrectal ultrasonography; PCA3; Anterior cancer; Transperineal prostate biopsy; Multiparametric magnetic resonance imaging;
Keywords: lncRNA; long/large noncoding RNA; Xist; X-inactive specific transcript; mESC; mouse embryonic stem cell; Evf2; embryonic ventral forebrain 2; Six3os; sine oculis-related homeobox 3 homolog, opposite strand; Dlx1as; distal-less homeobox 1, antisense; EGO;
Keywords: %fPSA; ratio of fPSA to tPSA (in percent) also known as f/tPSA ratio or percent free PSA; %[â 2]proPSA; percentage of [-2]proPSA to fPSA; A2M; alpha2-macroglobulin; ACT; alpha-1-antichymotrypsin; ANN; artificial neural network; API; alpha1-protease inh
Long noncoding RNAs act as regulators of autophagy in cancer
Keywords: lncRNA; long noncoding RNA; miRNA; microRNA; EMT; epithelial-mesenchymal transition; Atg; autophagy-related gene; HOTAIR; HOX antisense intergenic RNA; HCC; hepatocellular carcinoma; HULC; highly upregulated liver cancer; MALAT1; metastasis-associated lun
Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment
Keywords: Prostate cancer; Urine biomarkers; Early detection; Gene fusions; PCA3;
Long non-coding RNA: A newly deciphered “code” in prostate cancer
Keywords: Androgen receptor; LNCaP; Biomarker; PCa; prostate cancer; ncRNA; non-coding RNAs; lncRNA; long ncRNA; miRNA; microRNA; snRNA; small nuclear RNA; siRNA; small interfering RNA; tRNA; transfer RNA; rRNA; ribosomal RNA; PCA3; PCa antigen 3; PIN; prostatic in
Urinary PCA3 to predict prostate cancer in a cohort of 1015 patients
Keywords: Prostate cancer; Diagnosis; Prostate biopsies; Prediction; PCA3; Urinary testCancer de la prostate; Diagnostic; Biopsies prostatiques; Prédiction; PCA3; Test urinaire
Test urinaire PCA3 et diagnostic du cancer prostatique : étude à partir de 1015 patients
Keywords: Cancer de la prostate; Diagnostic; Biopsies prostatiques; Prédiction; PCA3; Test urinaireProstate cancer; Diagnosis; Prostate biopsies; Prediction; PCA3; Urinary test
The role of the prostate cancer gene 3 urine test in addition to serum prostate-specific antigen level in prostate cancer screening among breast cancer, early-onset gene mutation carriers
Keywords: PSA; prostate cancer gene 3; PCA3; BRCA2; marker; diagnostic value;
Does PCA3 Really Help Urologists?
Keywords: prostate; prostatic neoplasms; biological markers; prostate cancer antigen 3; human; biopsy; AS; active surveillance; FDA; Food and Drug Administration; MRI; magnetic resonance imaging; PCa; prostate cancer; PCA3; PCa gene 3; PSA; prostate specific antige
Real-time PCR PCA3 assay is a useful test measured in urine to improve prostate cancer detection
Keywords: Prostate cancer; PCA3; PSA; Urinary biomarkers
Diagnostic and predictive value of urine PCA3 gene expression for the clinical management of patients with altered prostate-specific antigen
Keywords: PCA3; Prostate-specific antigen; Screening; Prostate cancer; Gleason; Tumor aggressivenessPCA3; Antígeno prostático específico; Cribado; Cáncer de próstata; Gleason; Agresividad tumoral
The Roles of Multiparametric Magnetic Resonance Imaging, PCA3 and Prostate Health Index-Which is the Best Predictor of Prostate Cancer after a Negative Biopsy?
Keywords: prostatic neoplasms; biopsy; magnetic resonance imaging; prostate cancer antigen 3; human; bGS; biopsy Gleason score; DCA; decision curve analysis; DRE; digital rectal examination; DWI; diffusion weighted imaging; %fPSA; free PSA rate; mp-MRI; multiparame
Identification of miR-187 and miR-182 as Biomarkers of Early Diagnosis and Prognosis in Patients with Prostate Cancer Treated with Radical Prostatectomy
Keywords: prostatic neoplasms; biological markers; microRNAs; diagnosis; prognosis; BPFS; biochemical PFS; DRE; digital rectal examination; FDR; false discovery rate; FFPE; formalin fixed, paraffin embedded; PCA3; prostate cancer antigen 3; PCR; polymerase chain re
Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
Keywords: PCA3; Prognostic; Prostate cancer; TMPRSS2-ERG; Urinary biomarkers;
PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience
Keywords: Prostate cancer; PCA3; Diagnostic; PSA; Key messages; Early prostate cancer detection
PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study
Keywords: prostate; prostatic neoplasms; biopsy; prognosis; prostate cancer antigen 3, human; DRE; digital rectal examination; LR; logistic regression; NPV; negative predictive value; PCa; prostate cancer; PCA3; PCa gene 3; PPV; positive predictive value; PSA; pros
Le score PCA3 et l'IRM prostatique permettent-ils de sélectionner les patients candidats a une première série de biopsies prostatiques ?
Keywords: Biopsie; Cancer de prostate; PCA3; IRM; Diagnostic initial; Biopsy; Prostate cancer; PCA3; MRI; Initial diagnosis;
Genome-wide Association Study Identifies Genetic Determinants of Urine PCA3 Levels in Men
Keywords: GWAS; genome-wide association study; REDUCE; REduction by DUtasteride of prostate Cancer Events; PCa; prostate cancer; PSA; prostate-specific antigen; PCA3; prostate cancer gene 3; MSMB; β-microseminoprotein; KLK2; kallikrein-related peptidase 2; KLK3; k
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
Keywords: phi; prostate health index; PCA3; prostate cancer antigen 3; PSA; prostate-specific antigen; DRE; digital-rectal examination; tPSA; total PSA; fPSA; free PSA; p2PSA; [â 2]proPSA; f/t PSA; free/total PSA; HGPIN; high grade prostatic intraepithelial neop
Glycosylation of prostate specific antigen and its potential diagnostic applications
Keywords: 2-DE; two-dimensional electrophoresis; AA(A); Aleuria aurantia agglutinin; AMACR; α-methylacyl-CoA racemase; BPH; benign prostatic hyperplasia; BPSA; benign prostatic hyperplasia associated PSA; Con A; Concanavalin A; CE; capillary electrophoresis; ELLA;
Serum Index Test %[-2]proPSA and Prostate Health Index are More Accurate than Prostate Specific Antigen and %fPSA in Predicting a Positive Repeat Prostate Biopsy
Keywords: prostate-specific antigen; prostatic neoplasms; biopsy; early detection of cancer; diagnosis; DCA; decision curve analysis; DRE; digital rectal examination; fPSA; free prostate specific antigen; %fPSA; free/total prostate specific antigen; PCa; prostate c
Development and Internal Validation of a Prostate Health Index Based Nomogram for Predicting Prostate Cancer at Extended Biopsy
Keywords: prostate; prostate-specific antigen; nomograms; prostatic neoplasms; biopsy; DCA; decision curve analysis; DRE; digital rectal examination; fPSA; free PSA; f/tPSA; free-to-total PSA; p2PSA; [-2]proPSA; PCa; prostate cancer; PCA3; prostate cancer antigen
Cancer de la prostate : les marqueurs biologiques
Keywords: Cancer de la prostate; PSA; Kallicréïnes; PCA3; EPCA2; Prostate cancer; PSA; Kallicreins; PCA3; EPCA2;
PCA3: From basic molecular science to the clinical lab
Keywords: PCA3; DD3; Prostate cancer; Diagnostic; Marker
Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
Keywords: PCA3; Prostate biopsy; Prostate cancer detection; Staging; Targeted therapy
Prostate cancer
Keywords: Adenocarcinoma of the prostate; brachytherapy; Gleason score, HiFU; PCA3; prostate cancer; prostate-specific antigen; radical prostatectomy; robotic prostatectomy
Performance of the Prostate Cancer Antigen 3 (PCA3) Gene and Prostate-Specific Antigen in Prescreened Men: Exploring the Value of PCA3 for a First-line Diagnostic Test
Keywords: PCA3; Prostate specific antigen (PSA); Prostate cancer; Detection; Performance characteristics;
Performance of Prostate Cancer Antigen 3 (PCA3) and Prostate-Specific Antigen in Prescreened Men: Reproducibility and Detection Characteristics for Prostate Cancer Patients with High PCA3 Scores (≥100)
Keywords: Prostate cancer; Diagnosis; PCA3; PSA; Performance characteristics
Towards Early and More Specific Diagnosis of Prostate Cancer? Beyond PSA: New Biomarkers Ready for Prime Time
Keywords: PCA3; Prostate cancer; PSA; TMPRSS2-ERG gene fusions;
PCA3 Molecular Urine Assay Correlates With Prostate Cancer Tumor Volume: Implication in Selecting Candidates for Active Surveillance
Keywords: genes; neoplasm; prostatic neoplasms; prostate-specific antigen; DRE; digital rectal examination; GS; Gleason score; NPV; negative predictive value; PCA3; prostate cancer gene 3; PPV; positive predictive value; PSA; prostate specific antigen; TRUS; transr
Place du test urinaire PCA3 pour le diagnostic du cancer de la prostate
Keywords: Cancer de la prostate; Biomarqueur; Diagnostic; Urines; PCA3; Biopsies prostatiquesProstate cancer; Biomarker; Diagnosis; Urine; PCA3; Prostate biopsies
Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
Keywords: Diagnostic methods; PCA3; Prostate biopsy; Prostate cancer; Prostate specific antigen; Sensitivity; Specificity
Prostate cancer screening markers
Keywords: Prostate cancer screening; Biomarkers; PSA; PSA isoforms; Kallikrein; IGF; DD3; PCA3; uPM3;